Vertical transmission of HIV in New York State: A basis for statewide testing of newborns

AIDS Patient Care and STDs

Volumn 11, Issue 4, 1997, Pages 227-236

  Charbonneu, Tina T ^a   Wade, Nancy A ^b   Weiner, Leonard ^b   Omene, Jackson ^b   Frenkel, Lisa ^b   Wethers, Judith A ^b   Arpadi, Stephen ^b   Bamji, Marukh ^b   Frey, Henry M ^b   Gupta, Asha ^b   Conroy, James M ^b  

^a WADSWORTH CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN;

ARTICLE; DIAGNOSTIC ACCURACY; EARLY DIAGNOSIS; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN TISSUE; IMMUNOGLOBULIN BLOOD LEVEL; INFANT; INFECTION RATE; LOW BIRTH WEIGHT; MAJOR CLINICAL STUDY; NEWBORN; NEWBORN MONITORING; POLYMERASE CHAIN REACTION; UNITED STATES; VERTICAL TRANSMISSION;

BLOTTING, WESTERN; DISEASE TRANSMISSION, VERTICAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FALSE POSITIVE REACTIONS; FEMALE; HIV CORE PROTEIN P24; HIV INFECTIONS; HLA-D ANTIGENS; HUMANS; IMMUNOGLOBULINS; INFANT; INFANT, NEWBORN; LYMPHOCYTE COUNT; MALE; MASS SCREENING; NEW YORK; POLYMERASE CHAIN REACTION; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY;

EID: 18844469198     PISSN: 08935068     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Centers for Disease Control. Classification system for human immunodeficiency virus infection in children MMWR 1983;36:225-236.
2. Oxtoby M. Perinatally acquired HIV infection in the United States in Pediatrie AIDS: The Challenge of HIV Infection in Infants, Children and Adolescents. (Pizzo P and Wilfert C, eds) (2nd ed.). Baltimore: Williams and Wilkins, pp. 3-20, 1991.
3. Luzuriaga K, Mcquilken P, Somasundaran M, et al. Early viremia and immune responses in vertical human immunodeficiency vims type 1 infection. J Infect Dis 1993;167:1008-1013.
4. Borkowsky W, Krasinski K, Pollack H, et al. Early diagnosis of human immunodeficiency virus infection in children <6 months of age: Comparison of polymerase chain reaction, culture and plasma antigen capture techniques. J Infect Dis 1992;166: 616-619.
5. Brandt C, Rakusan T, Sison A, et al. Human immunodeficiency virus infection in infants during the first two months of life. Arch Pediatr Adolesc Med 1994;148:250-254.
6. Paul M, Tetali S, Lesser M, et al. Laboratory diagnosis of infection status in infants perinatally exposed to human immunodeficiency virus type 1. J Infect Dis 1996;173:68-76.
7. Nesheim S, Lindsay M, Sawyer M, et al. A prospective population-based study of HIV perinatal transmission. AIDS 1994;8:1293-8.
8. Comeau A, Harris J, McIntosh K, et al. Polymerase chain reaction in detecting HIV infection among seropositive infants: Relation to clinical status and age and to results of other assays. J Acq Immune Deficiency Syn 1992;5:27l-278.
9. Wiznia A, Lambert G, Dobrosyzcki J, et al, Virologic, immunologic, and clinical evaluation of HIV seroreverting children, J Pediatr 1994;125:352-355.
10. Kellogg D, Kwok S. Detection of human immunodeficiency virus. In: Innis, M, Gelfand, D, Sninsky, J, White, T, eds. PCR Protocols: A guide to methods and applications. Troy, MO: Academic Press, 1989:337.
11. Saiki R, Scharf S, Faloona F, et al. Enzymatic amplification of beta globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. Science 1985;230:1350-1354.
12. Schmidt G, Amiraian K, Frey H, et al. Densitometric analysis of western blot (immunoblot) assays for human immunodeficiency virus antibodies and correlation with clinical status, J Clin Microbiol 1987; 25:1993-1998.
13. Centers for Disease Control. Guidelines for the performance of CD4+ T-Cell determinations in persons with human immunodeficiency virus infection. MMWR 1992;41(RR-8):1-17.
14. Centers for Disease Control. 1994 revised guidelines for the performance of CD4+ T-cell determinations in persons with human immunodeficiency virus infection MMWR 1994;43(RR-3):1-21.
15. Yourno J. A method for nested PCR with single closed reaction tubes. PCR Methods and Applications 1992;2:6005.
16. New York Department of Health, AIDS in New York 1996, p. 16.
17. Comeau A, Pitt J, Hillyer G, et al. Early detection of human immunodeficiency virus on dried bloodspots: sensitivity across serial specimens. J Pediatr 1996; 129:111-118.
18. Nelson R, Price L, Halsey A, et al. Diagnosis of pediatric human immunodeficiency virus infection by means of a commercially available polymerase chain reaction gene amplification. Arch Pediatr Adolesc Med 1996;150:40-45.
19. Nesheim S, Lindsay M, Sawyer M, et al. A prospective population-based study of HIV perinatal transmission. AIDS 1994;8:1293-1298.
20. Miles S, Balden E, Magpantay L, et al. Rapid serologie testing with immune-complex-dissociated. HIV p24 antigen for early detection of HIV infection in neonates. N Engl J Med 1993;328:297-302.
21. Lewis D, Adu-Oppong A, Hollinger F, et al. Sensitivity of immune complex -dissociated p24 antigen testing for early detection of human immunodeficiency virus in infants. Clin Diag Lab Immunol 1995;2:87-90.
22. Andiman W, Silva T, Shapiro E, et al. Predictive value of the human immunodeficiency virus 1 antigen test in children born to infected mothers. Pediatr Infect Dis J 1992;11:436-440.
23. Nishanian P, Hofman B, Wang Y, et al. Serum soluble CDS molecule is a marker of CD8 T-cell activation in HIV-1 disease. AIDS 1991;5:805-812.
24. Gonzalez-Molina A, Otero M, Perez-Tamirit A, et al. Longitudinal studies of serum immune activation markers and IgD in children born to HIV infected women. 6th International Conference on AIDS 1991 Abstract W.A. 1184.
25. Gesner M, Dijohn D, Krasinski K, et al. Increased soluble CD8 in human immunodeficiency virus 1- infected children in the first month and year of life. Pediatr Infect Dis J 1994;13:896-898.
26. Scott G, Buck B, Leterman J, et al. Acquired immunodeficiency syndrome in infants. N Engl J Med 1984;310:76-81.
27. Nair P, Alger L, Hines S, et al. Maternal and neonatal characteristics associated with HIV infection in infants of seropositive women. J Acquir Defic Syndr 1993;6:298-302.
28. McIntosh K, Pitt J, Brambilla D, et al. Blood culture in the first 6 months of life for the diagnosis of vertically transmitted human immunodeficiency virus infection. J Infect Dis 1994;170:996-1000.
29. Thomas P, Weedon J, Krasinski K, et al. Maternal predictors of perinatal human immunodeficiency virus transmission, Pediatr Infect Dis J 1994;13:489-495.
30. 30.The European Collaborative Study. Children born to women with HIV-1 infection: natural history and risk of transmission. Lancet 1991;1:252-260.
31. The HIV Infection in Newborns French Collaborative Study Group. Comparison of vertical human immunodeficiency virus type 2 and human immunodeficiency virus type 1 in the French prospective cohort. Pediatr Infect Dis J 1994;13:502-506.
32. Landesman S, Kalish L, Burns D, et al. Obstetrical factors and the transmission of human immunodefi- ciency virus type 1 from mother to child. N Engl J Med 1996;334:1617-1623.
33. Abrams E, Metheson P, Thomas P, et al. Neonatal predictors of infection status and early death among 332 infants at risk of HIV-1 infection monitored prospectively from birth. Pediatrics 1995;96:451-458.
34. Hutto C, Parks W, Lai S, et al. A hospital based prospective study of perinatal infection with human immunodeficiency virus. J Pediatr 1991;118:347-353.
35. Mayers M, Davenny K, Schoenbaum E, et al. A prospective study of infants of human immunodeficiency seropositive and seronegative women with a history of intravenous drug use or of intravenous drug-using sex partners, in the Bronx, New York City. Pediatrics 1991;88:1248-1256.
36. Dickover R, Garratty E, Herman S, et al. Identification of levels of maternal HIV-1 RNA associated with risk of perinatal transmission, Effect of maternal zidovudine treatment on viral load. JAMA 1996; 275(8):599-605.
37. Shaffer R, Chotpitayasunnondh T, Roongpisuthipong A, et al High maternal viral load predicts perinatal HIV-1 transmission and early infant progression. In: Program and abstracts of the 3rd Conference on Retrovirus and opportunistic Infections, American Society for Microbiology, 1996. p. 58 (Abstract 30).
38. Phillips A, Hill A, Eron J, et al. The prognostic value of HIV RNA levels. In: Program and abstracts of the 3rd Conference on Retrovirus and Opportunistic Infections, American Society for Microbiology, 1996. p. 52 (Abstract 32).
39. Bryson Y. The role of plasma RNA as a determinant of risk in maternal-fetal HIV transmission and early progression of in perinatally infected infants. In: Program and abstracts of the 3rd Conference on Retrovirus and Opportunistic Infections, American Society for Microbiology, 1996. p, 175 (Abstract S25).
40. Hammer D, Katzenstein M, Hughes M, et al. In: Program and abstracts of the 3rd Conference on Retrovirus and Opportunistic Infections, American Society for Microbiology, 1996, p. 175 (Abstract S24).
41. Fang G, Burger H, Crimson R, et al. Maternal plasma human immunodeficiency virus type 1 RNA level: a determinant and projected threshold for mother-tochild transmission. Proc Natl Acad Sci 1995;92( 26):12100-121004.
42. Weiser B, Nachman S, Tropper P, et al. Quantitation of human immunodeficiency virus type 1 during pregnancy: relationship of viral titer to mother-to-child transmission and stability of viral load. Proc Natl Acad Sci USA 1994;91(17);8037-8041.
43. Connor E, Sperling R, Gelber R, et al. Reduction of maternal-infant transmission of human immunodeficiency virus with zidovudine treatment. N Engl J Med 1994;331:1173-1180.
44. Wilfert, C. Prevention of perinatal transmission of human immunodeficiency virus: A progress report 2 years after completion of AIDS Clinical Trials Group Trial 076. Clin Infect Dis 1996;23:438-441.